Actionable news
All posts from Actionable news
Actionable news in NK: NantKwest Inc,

NantKwest Continues the Strengthening of Its Leadership Team and Appoints a Seasoned Bioprocessing Manufacturing Executive


NantKwest, Inc. (Nasdaq: NK), a clinical-stage immunotherapy company focused on harnessing the power of the innate immune system by using natural killer cells to treat cancer, infectious diseases and inflammatory diseases, today announced the appointment of Stephen Farrand, Ph. D., as senior vice president of global manufacturing.

“Dr. Farrand is an experienced executive, with an impressive track record of achievement in chemistry, manufacturing and control (CMC) development,” said Patrick Soon-Shiong, M.D., chairman and chief executive officer of NantKwest. “He brings expertise in all aspects of biologics development and manufacturing, as well as a full understanding of cGMP compliance requirements and the regulatory environment. With our recent acquisition of two production sites in Southern California, including a 45,000 square foot facility in Torrey Pines, Dr. Farrand fills a key function as we expand in-house production capacity for our aNK, haNK and taNK products.”

Prior to joining NantKwest, Dr. Farrand was vice president bioprocess development for Merck Research Laboratories, where his leadership was instrumental to the successful development and commercialization of Merck’s PD-1 checkpoint...